A healthcare CEO said he would 'fight and die' for Martin Shkreli's 'right to be a douche'
Screenshot
The latest addition to the debate comes from Athenahealth CEO Jonathan Bush, who told CNBC's Carl Quintanilla that he would "fight and die for Shkreli's right to be a douche" but that Shkreli was definitely "being a douche."
Athenahealth provides cloud-based services for healthcare and point-of-care mobile apps.
Shkreli gained notoriety after Turing bought a lifesaving AIDS drug called Daraprim and raised the price 5,000%.
Bush, who is known for his colorful commentary and quirky salesmanship, has his reasons for thinking Shkreli has a "right to be a douche."
Quintanilla then asked whether Bush was legitimizing Shkreli's pricing structure.
"Here's how it works ... It would be easier if there were many buyers and not just one, because then some of the buyers could say, 'Hey fangool, I'm not including you in my benefit,'" Bush said. "But when it becomes a mandate from the people, your negotiation power goes way down because this kid's got this invention and he's like, 'Well do you want it or not?' If some people actually said 'not,' he would be forced to behave a little better. But since it's illegal for anyone to say 'not,' he gets to be a jerk."
"That's a market," he said.
Here's the quick clip via Quintanilla's Twitter feed.
With @jonathan_bush, talking #MartinShkreli @cnbchttps://t.co/SgWnNLUCnN
- Carl Quintanilla (@carlquintanilla) February 5, 2016
- Thailand is now welcoming Indians with open arms, but are its drought-hit islands really prepared for a tourism influx?
- Thoughtful gift ideas to make Mother's Day extra special
- Muslims up, Hindus down: What’s the larger picture behind India’s religious population trends?
- Scooch over magic mushrooms, toad venom could be the next big psychedelic for depression and anxiety!
- TBO Tek IPO allotment – How to check allotment, GMP, listing date and more